a:5:{s:8:"template";s:10315:"<!DOCTYPE html>
<html lang="en"><head>
<meta charset="utf-8"/>
<title>{{ keyword }}</title>
<meta content="width=device-width,initial-scale=1,user-scalable=no" name="viewport"/>
<link href="//fonts.googleapis.com/css?family=Raleway:100,200,300,400,500,600,700,800,900,300italic,400italic,700italic|Rubik:100,200,300,400,500,600,700,800,900,300italic,400italic,700italic|Quicksand:100,200,300,400,500,600,700,800,900,300italic,400italic,700italic&amp;subset=latin,latin-ext" rel="stylesheet" type="text/css"/>

<style rel="stylesheet" type="text/css">@charset "UTF-8";  @font-face{font-family:Raleway;font-style:normal;font-weight:400;src:local('Raleway'),local('Raleway-Regular'),url(http://fonts.gstatic.com/s/raleway/v14/1Ptug8zYS_SKggPNyCMISg.ttf) format('truetype')}@font-face{font-family:Raleway;font-style:normal;font-weight:500;src:local('Raleway Medium'),local('Raleway-Medium'),url(http://fonts.gstatic.com/s/raleway/v14/1Ptrg8zYS_SKggPNwN4rWqhPBQ.ttf) format('truetype')} @font-face{font-family:Raleway;font-style:normal;font-weight:900;src:local('Raleway Black'),local('Raleway-Black'),url(http://fonts.gstatic.com/s/raleway/v14/1Ptrg8zYS_SKggPNwK4vWqhPBQ.ttf) format('truetype')}.has-drop-cap:not(:focus):first-letter{float:left;font-size:8.4em;line-height:.68;font-weight:100;margin:.05em .1em 0 0;text-transform:uppercase;font-style:normal} .clearfix:after{clear:both}a{color:#303030}.clearfix:after,.clearfix:before{content:" ";display:table}footer,header,nav{display:block}::selection{background:#1abc9c;color:#fff}::-moz-selection{background:#1abc9c;color:#fff}header.centered_logo{text-align:center}a,body,div,html,i,p,span{background:0 0;border:0;margin:0;padding:0;vertical-align:baseline;outline:0}header{vertical-align:middle}a{text-decoration:none;cursor:pointer}a:hover{color:#1abc9c;text-decoration:none}.wrapper,body{background-color:#f6f6f6}html{height:100%;margin:0!important;-webkit-transition:all 1.3s ease-out;-moz-transition:all 1.3s ease-out;-o-transition:all 1.3s ease-out;-ms-transition:all 1.3s ease-out;transition:all 1.3s ease-out}body{font-family:Raleway,sans-serif;font-size:14px;line-height:26px;color:#818181;font-weight:400;overflow-y:scroll;overflow-x:hidden!important;-webkit-font-smoothing:antialiased}.wrapper{position:relative;z-index:1000;-webkit-transition:left .33s cubic-bezier(.694,.0482,.335,1);-moz-transition:left .33s cubic-bezier(.694,.0482,.335,1);-o-transition:left .33s cubic-bezier(.694,.0482,.335,1);-ms-transition:left .33s cubic-bezier(.694,.0482,.335,1);transition:left .33s cubic-bezier(.694,.0482,.335,1);left:0}.wrapper_inner{width:100%;overflow:hidden}header{width:100%;display:inline-block;margin:0;position:relative;z-index:110;-webkit-backface-visibility:hidden}header .header_inner_left{position:absolute;left:45px;top:0}header .container_inner .header_inner_left{position:absolute;left:0;top:0}.header_bottom,.q_logo{position:relative}header.menu_position_left .header_inner_left{z-index:101}.header_inner_right{float:right;position:relative;z-index:110}.header_bottom{padding:0 45px;background-color:#fff;-webkit-transition:all .2s ease 0s;-moz-transition:all .2s ease 0s;-o-transition:all .2s ease 0s;transition:all .2s ease 0s}.logo_wrapper{height:100px;float:left}.q_logo{top:50%;left:0}header.fixed{-webkit-transition:left .33s cubic-bezier(.694,.0482,.335,1);-moz-transition:left .33s cubic-bezier(.694,.0482,.335,1);-o-transition:left .33s cubic-bezier(.694,.0482,.335,1);-ms-transition:left .33s cubic-bezier(.694,.0482,.335,1);transition:left .33s cubic-bezier(.694,.0482,.335,1);width:100%;position:fixed;z-index:110;top:0;left:0}header.centered_logo .header_inner_left{float:none;position:relative;display:block;margin:20px 0 10px;left:0}header.centered_logo .header_inner_right{display:inline-block;vertical-align:middle}header.centered_logo .logo_wrapper{float:none;height:auto!important}header.centered_logo .q_logo{top:0}header.centered_logo .header_inner_right{float:none;position:relative}header.centered_logo nav.main_menu,header.centered_logo nav.main_menu.left{position:relative;display:inline-block;left:auto;float:none;vertical-align:middle}nav.main_menu{position:absolute;left:50%;z-index:100;text-align:left}nav.main_menu.left{position:relative;left:auto;float:left;z-index:101}nav.mobile_menu{background-color:#fff}nav.mobile_menu{display:none;width:100%;position:relative}nav.mobile_menu{float:left;top:0;text-align:left;overflow:hidden;z-index:100}.side_menu_button_wrapper{display:table}.side_menu_button{cursor:pointer;display:table-cell;vertical-align:middle;height:100px}.content{background-color:#f6f6f6}.container,.content{z-index:100;position:relative}.content{margin-top:0}.container{padding:0;width:100%}.container_inner{width:1100px;margin:0 auto}.header_bottom .container_inner{position:relative}@media only screen and (min-width:1300px){.qode_grid_1200 .container_inner{width:1200px}}.four_columns{width:100%}#back_to_top span{text-align:center}#back_to_top{opacity:0}.footer_bottom{text-align:center}.footer_top_holder,footer{display:block}footer{width:100%;margin:0 auto;z-index:100;position:relative}footer .container_inner{position:relative}.footer_top_holder{background-color:#262626;position:relative}.footer_top{padding:20px 0 20px}.footer_top.footer_top_full{padding:48px 24px}.footer_bottom_holder{display:block;background-color:#1b1b1b}.footer_bottom{display:table-cell;font-size:12px;line-height:22px;height:53px;width:1%;vertical-align:middle}.footer_bottom p{margin:0}#back_to_top{color:#cdcdcd;height:auto;position:fixed;bottom:65px;margin:0;z-index:10000;-webkit-transition:all .3s ease 0s;-moz-transition:all .3s ease 0s;-o-transition:all .3s ease 0s;transition:all .3s ease 0s;right:25px;visibility:hidden;-webkit-backface-visibility:hidden}#back_to_top>span{width:52px;height:52px;line-height:52px;text-decoration:none;-o-border-radius:52px;-moz-border-radius:52px;-webkit-border-radius:52px;border-radius:52px;-webkit-transition:all .2s ease 0s;-moz-transition:all .2s ease 0s;-o-transition:all .2s ease 0s;border:2px solid #e8e8e8;background:0 0}#back_to_top span i{-webkit-transition:color .2s ease 0s;-moz-transition:color .2s ease 0s;-o-transition:color .2s ease 0s}#back_to_top span i{font-size:22px;color:#b0b0b0;line-height:52px}#back_to_top:hover>span{background-color:#e8e8e8}.header_top_bottom_holder{position:relative}:-moz-placeholder,:-ms-input-placeholder,::-moz-placeholder,::-webkit-input-placeholder{color:#959595;margin:10px 0 0}.side_menu_button{position:relative}.blog_holder.masonry_gallery article .post_info a:not(:hover){color:#fff}.blog_holder.blog_gallery article .post_info a:not(:hover){color:#fff}.blog_compound article .post_meta .blog_like a:not(:hover),.blog_compound article .post_meta .blog_share a:not(:hover),.blog_compound article .post_meta .post_comments:not(:hover){color:#7f7f7f}.blog_holder.blog_pinterest article .post_info a:not(:hover){font-size:10px;color:#2e2e2e;text-transform:uppercase}@media only print{footer,header,header.page_header{display:none!important}.container_inner{max-width:80%}.wrapper,body,html{padding-top:0!important;margin-top:0!important;top:0!important}}@media only screen and (max-width:1200px){.container_inner{width:950px}}@media only screen and (min-width:1000px) and (max-width:1200px){.header_bottom .container_inner{width:100%}}@media only screen and (max-width:1000px){.container_inner{width:768px}.header_inner_left,header{position:relative!important;left:0!important;margin-bottom:0}.content{margin-bottom:0!important}header{top:0!important;margin-top:0!important;display:block}.header_bottom{background-color:#fff!important}header.centered_logo .header_inner_left{margin:0}header.centered_logo .header_inner_right{float:right}header.centered_logo .logo_wrapper{height:100px!important}.logo_wrapper{position:absolute}.main_menu{display:none!important}nav.mobile_menu{display:block}.logo_wrapper{display:table}.logo_wrapper{height:100px!important;left:50%}.q_logo{display:table-cell;position:relative;top:auto;vertical-align:middle}.side_menu_button{height:100px!important}.content{margin-top:0!important}}@media only screen and (max-width:768px){.container_inner{width:600px}}@media only screen and (max-width:600px){.container_inner{width:420px}}@media only screen and (max-width:480px){.container_inner{width:300px}.header_bottom,footer .container_inner{padding:0 25px}.header_bottom .container_inner,footer .container_inner{width:auto}.footer_bottom{line-height:35px;height:auto}}@media only screen and (max-width:420px){.header_bottom,footer .container_inner{padding:0 15px}}@media only screen and (max-width:350px){.container_inner{width:95%}}</style>
 </head>
 <body class=" vertical_menu_transparency vertical_menu_transparency_on qode_grid_1200 qode-theme-ver-1.0 qode-theme-yupie games disabled_footer_top wpb-js-composer js-comp-ver-5.6 vc_responsive" itemscope="" itemtype="http://schema.org/WebPage">
<div class="wrapper">
<div class="wrapper_inner">
<header class=" centered_logo scroll_header_top_area dark fixed scrolled_not_transparent header_style_on_scroll menu_position_left page_header">
<div class="header_inner clearfix">
<div class="header_top_bottom_holder">
<div class="header_bottom clearfix" style="">
<div class="container">
<div class="container_inner clearfix">
<div class="header_inner_left">
<div class="logo_wrapper">
<div class="q_logo">
<h2>{{ keyword }}</h2>
</div>
</div> </div>
<nav class="main_menu drop_down left">
</nav>
<div class="header_inner_right">
<div class="side_menu_button_wrapper right">
<div class="side_menu_button">
</div>
</div>
</div>
<nav class="mobile_menu">
</nav> </div>
</div>
</div>
</div>
</div>
</header> <a href="#" id="back_to_top">
<span class="fa-stack">
<i class="qode_icon_font_awesome fa fa-arrow-up "></i> </span>
</a>
<div class="content ">
<div class="content_inner ">
{{ text }}
</div>
</div>
<footer>
<div class="footer_inner clearfix">
<div class="footer_top_holder">
<div class="footer_top footer_top_full">
<div class="four_columns clearfix">
{{ links }}
</div>
</div>
</div>
<div class="footer_bottom_holder">
<div class="container">
<div class="container_inner">
<div class="footer_bottom">
<div class="textwidget"><p>{{ keyword }} 2020</p>
</div>
</div>
</div>
</div>
</div>
</div>
</footer>
</div>
</div>
</body></html>";s:4:"text";s:8490:"ALCOHOL/AMMONIA Reviewed January 2012. 2010 Update: In August, the AACB Scientific and Regulatory Affairs Committee updated the guidelines, tightening the allowable limits of performance for 21 analytes, as well as loosened the limits for 8 analytes. ANALYTE TOTAL ALLOWABLE ERROR SOURCE Adrenaline ± 30 up to 100 nmol/L; 30% > 100 nmol/L RCPA Adrenocorticotropic hormone (ACTH) ± 2.0 up to 20 pmol/L; 10% > 20 pmol/L RCPA ALA, urine ± 8 up to 32 µmol/L; 25% > 32 µmol/L RCPA Alanine 26.6% BV Alanine aminotransferase (ALT) 27.48% BV Alanine aminotransferase (ALT) 35% CFX Alanine aminotransferase (ALT) 20% CLIA, … Various Screening of urine to monitor/diagnose various … For the TPT-based approach, 16 assays showed σ CLIA > 3, and 12 assays showed σ WS/T > 3. [Please note: This is an unauthorized listing of RCPA allowable limits of performance (ALP). Accreditation A ssociation for Hospitals and Health ; S ystems/Healthcare Facilities Accreditation Program . CLIA 2019 proposal is the first time that CLIA has mandated an allowable limit for HbA1c proficiency testing. Comparability of Laboratory Tests James O. Westgard University of Wisconsin Medical School Westgard QC, Inc. Madison, WI www.westgard.com 1 CLIA –Clinical Laboratory Improvement Amendments. 124 ; AABB . Certificate of Accreditation by Organization (Non-Exempt Only) Number of Labs COLA ; 6,091 . The Division of Clinical Laboratory Improvement & Quality, within the Quality, Safety & Oversight Group, under the Center for Clinical Standards and Quality (CCSQ) has the responsibility for implementing the CLIA Program. Fractional Methaemoglobin Download Ebook Recommended Total Allowable Error Limits Laboratories Are Recommended Total Allowable Error Limits Laboratories Are If you ally obsession such a referred TEa (allowable or desirable total error) – A quality requirement that sets a limit for combined imprecision (random error) and bias (inaccuracy, or systematic error) … CLIA Acceptable Test Performance Criteria CLIA 88 has publisheded acceptable performance criteria for analytes that are graded in proficiency surveys. Alcohol ± 2.0 up to 20.0 mmol/L; 10% > 20.0 mmol/L Ammonia ± 5 up to 50 µmol/L; 20% > 50 µmol/L. "QC Design: Things You Need to Know" series is intended to educate the audience on statistical quality control design and testing. All laboratory/method CVs declined from ~5-6% in 2000 to ~3.5% by 2013, and reached <3% by 2018. TESTS GRANTED WAIVED STATUS UNDER CLIA. o CLIA t bilit li it f i bilit i fi i t ti lt CLIA acceptability limits for variability in proficiency testing results (403.909 – 403.959) o Range of actual PT results for the analyte/method Gentamicin ± 0.2 up to 2.0 mg/L; 10% > 2.0 mg/L Tobramycin ± 0.2 up to … Total Allowable Errors for chemistry analytes found in the CLIA Proficiency Testing Criteria6. CLIA Exempt States Number of Labs New York . 1996 1995 1994* 1993 Total # Labs: 157,002 152,434 150,143 154,740 . Lactate dehydrogenase 1 isoform (LDH1) Total Allowable Error: Lactate dehydrogenase 2 isoform (LDH2) Total Allowable Error: Lactate dehydrogenase 3 isoform (LDH3) Total Allowable Error: Lactate dehydrogenase 4 isoform (LDH4) Total Allowable Error: Lactate dehydrogenase 5 isoform (LDH5) Total Allowable Error: Lactate-CSF Total Allowable Error In total, CLIA covers approximately 260,000 laboratory entities. Allowable Limits of Performance . Listen to the Dr. Lakshmi Kuchipudi-Yerneni discuss Allowable Total Error (TEa) in this September 2014 Pearl of Laboratory Medicine. ± 3 up to 100 g/L; 3% > 100 g/L . Cruise Lines International Association (CLIA), the world’s largest cruise industry trade association, has released the 2019 Cruise Trends and State of the Cruise Industry Outlook. The CLIA 2019 proposal is the first time that CLIA has mandated an allowable limit for HbA1c proficiency testing.  5,518 . Question: Are there any officially published recommendations from CAP or CLIA regarding acceptable “comparison limits” to backup methods? American Society For Veterinary Clinical Pathology 2424 American Lane Madison, WI 53704. Medical laboratories play essential roles in measurement of analyte in clinical sample for the diagnosis and monitoring of diseases. Programs, Analytes and Allowable Limits of Performance . The Joint Commission ; 1,995 . Table 1. This list includes updates from Change Request FFS 10958 . A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Objective . CPT CODE(S) TEST NAME MANUFACTURER USE . Read Online Recommended Total Allowable Error Limits Laboratories Arehelps you download books and articles related to science. This page contains information about The Clinical Laboratory Improvement Amendments (CLIA) that regulate laboratory testing. and CLIA Waiver by Application Studies Guidance for Industry and Food and Drug Administration Staff Document issued on February 26, 2020. The objective of the CLIA program is to ensure quality laboratory testing. Standardization and improved performance of HbA1c assays were a necessary hurdle, which allowed the accep- CLIA UPDATE – July 2019 . Telephone: +1-608-443-2479 Fax: +1-608-443-2474 ANTIBIOTICS Reviewed April 2013 Amikacin ± 2.0 up to 19.9 mg/L; 10% > 19.9 mg/L . In addition to monitoring glycemia in patients with diabetes, HbA1c is recommended for diabetes diagnosis. On February 4, 2019, new CLIA "Proposed Rules" were published in the Federal Register to expand the list of regulated analytes and define new criteria for acceptable performance for proficiency testing (PT) [1]. CLIA does not provide proficiency testing criteria for analytes in urine. Address correspondence to this author at: 1001, Potrero Ave., San Francisco, CA 94110. CLIA; Clinical Laboratory Improvement Amendments of 1988; CV; Coefficient of variation; dpm; Defects per million; EQA; External quality assessment; NCCL; National Center for Clinical Laboratories; QGI; Quality goal index; RCPA; Royal College of Pathologists of Australasia; Tea; Total allowable error; tPSA; Total prostate‐specific antigen Washington ; 4,251 . For the IQC-based approach, 19 and 16 assays showed σ CLIA > 3 and σ WS/T > 3, respectively. Conclusions: Both methods can be used as references for calculating sigma metrics and designing QC schedules in clinical laboratories. Thus, data generated from the laboratory have to be reliable for which strict quality assurance is maintained. The practice of using the σ to improve clinical laboratory quality has been in place for nearly two decades. Form 4562 Line 12 - The total allowable Section 179 does not match the sum of allowable Section 179 SOLVED • by Intuit • ProSeries Basic • 2 • Updated 6 days ago Problem Description As all laboratory equipment ages and contains components that may degrade with time, initial and periodically scheduled performance assessment is required to … Fractional Carboxyhaemoglobin ± 2.0% . Answer: Analytical Quality Requirements based on CLIA regulations can be found in the links below: Total in non -exempt states: 149,055 145,124 144,079 152,250 College of American Pathologists ; 6,409 . Background . In addition to monitoring glycemia in patients with dia-betes, HbA1c is recommended for diabetes diagnosis. CV (coefficient of variation) – A measure of imprecision (random error), biologic variation, or other variability in a population; mathematically, CV is standard deviation (SD) divided by the mean and expressed as a percentage.3 Comparability Testing – A quality assurance procedure in which measurement results from two or … Fax 415-206-3045; e-mail alan.wu@ucsf.edu. The report offers a look at the trends impacting cruise travel in the coming year and beyond … Fractional Oxyhaemoglobin ± 3 up to 75.0%; 4% > 75.0% . IRON (FE) ± 20% CLIA Lactate Dehydrogenase (LDH) ± 20% CLIA Magnesium (MG) ± 25% CLIA PCO 2 ± 5 mmHg or 8% (greater) CLIA pH ± 0.04 CLIA PO 2 ± 3 SD CLIA Potassium (K) ± 0.5 mmol/L CLIA Protein, Total (TP) ± 10% CLIA Sodium (NA) ± 4 mmol/L CLIA Triglycerides (TRIG) ± 25% ± 15% CLIA NCEP Urea (UREA) ± 2 mg/dL or 9% (greater) CLIA 81002 Dipstick or tablet reagent urinalysis – non-automated for bilirubin, glucose, hemoglobin, ketone, leukocytes, nitrite, pH, protein, specific gravity, and urobilinogen . For official and up-to-date goals, consult the RCPA directly .] ";s:7:"keyword";s:31:"total allowable error clia 2019";s:5:"links";s:744:"<a href="http://truck-doctor.com/large-vented-wxqhrf/euclid%27s-c-finder-fix-4fe21e">Euclid's C-finder Fix</a>,
<a href="http://truck-doctor.com/large-vented-wxqhrf/miku-smart-baby-monitor-canada-4fe21e">Miku Smart Baby Monitor Canada</a>,
<a href="http://truck-doctor.com/large-vented-wxqhrf/cross-country-ski-packages-canada-4fe21e">Cross Country Ski Packages Canada</a>,
<a href="http://truck-doctor.com/large-vented-wxqhrf/allosaurus-vs-spinosaurus-who-would-win-4fe21e">Allosaurus Vs Spinosaurus Who Would Win</a>,
<a href="http://truck-doctor.com/large-vented-wxqhrf/alpecin-caffeine-shampoo-clicks-4fe21e">Alpecin Caffeine Shampoo Clicks</a>,
<a href="http://truck-doctor.com/large-vented-wxqhrf/any-time-soon-4fe21e">Any Time Soon</a>,
";s:7:"expired";i:-1;}